Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections
about
Crystal structures of penicillin-binding protein 2 from penicillin-susceptible and -resistant strains of Neisseria gonorrhoeae reveal an unexpectedly subtle mechanism for antibiotic resistanceThe use of cephalosporins for gonorrhea: the impending problem of resistanceAntimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and futureMicrobial antigenic variation mediated by homologous DNA recombinationHigh-throughput screening for novel inhibitors of Neisseria gonorrhoeae penicillin-binding protein 2Genomic Epidemiology of Gonococcal Resistance to Extended-Spectrum Cephalosporins, Macrolides, and Fluoroquinolones in the United States, 2000-2013Neisseria gonorrhoeae Evades Calprotectin-Mediated Nutritional Immunity and Survives Neutrophil Extracellular Traps by Production of TdfH.Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012Functional characterization of antibodies against Neisseria gonorrhoeae opacity protein loopsThe epidemiology of gonorrhoea in Norway, 1993-2007: past victories, future challenges.Various penA mutations together with mtrR, porB and ponA mutations in Neisseria gonorrhoeae isolates with reduced susceptibility to cefixime or ceftriaxone.A survey of primary care physician practices in antibiotic prescribing for the treatment of uncomplicated male gonoccocal urethritis.Lactobacillus jensenii surface-associated proteins inhibit Neisseria gonorrhoeae adherence to epithelial cellsInsights in public health: The hidden epidemic: sexually transmitted diseases in 2014.DNA uptake sequence-mediated enhancement of transformation in Neisseria gonorrhoeae is strain dependentMolecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.Successful treatment of uncomplicated gonococcal urethritis in HIV-infected patients with single-dose oral cefpodoxime.Sexually transmitted diseases treatment guidelines, 2015.Developing a system to predict laboratory-confirmed chlamydial and/or gonococcal urethritis in adult male emergency department patients.Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, CanadaAntimicrobial susceptibility and genetic characteristics of Neisseria gonorrhoeae isolates from India, Pakistan and Bhutan in 2007-2011.The efficacy and safety of gentamicin plus azithromycin and gemifloxacin plus azithromycin as treatment of uncomplicated gonorrheaAnalysis of Neisseria gonorrhoeae azithromycin susceptibility in the United States by the Gonococcal Isolate Surveillance Project, 2005 to 2013.Emergence of quinolone resistance and cephalosporin MIC creep in Neisseria gonorrhoeae isolates from a cohort of young men in Kisumu, Kenya, 2002 to 2009.Molecular Diagnosis of Sexually Transmitted Chlamydia trachomatis in the United States.Gonorrhea infection in women: prevalence, effects, screening, and management.Antimicrobial resistant gonorrhea in Atlanta: 1988-2006.Diffusion of antibiotics through the PilQ secretin in Neisseria gonorrhoeae occurs through the immature, sodium dodecyl sulfate-labile form.Azithromycin for PID beats doxycycline on all counts.Azithromycin resistance and its mechanism in Neisseria gonorrhoeae strains in Hyogo, Japan.An insight into the drug resistance profile & mechanism of drug resistance in Neisseria gonorrhoeae.Sexually transmitted proctitis.Comparison of Antimicrobial Susceptibility of Urogenital Neisseria gonorrhoeae Isolates Obtained From Women and Men.Sexually transmitted disease (STD) update: a review of the CDC 2010 STD treatment guidelines and epidemiologic trends of common STDs in Hawai'i.Antibiotic resistance in Neisseria gonorrhoeae: origin, evolution, and lessons learned for the future.Gonococcal susceptibility to cephalosporins--Hawaii, 2003 to 2011Beyond the Crystal Structure: Insight into the Function and Vaccine Potential of TbpA Expressed by Neisseria gonorrhoeae.Factors related to increasing prevalence of resistance to ciprofloxacin and other antimicrobial drugs in Neisseria gonorrhoeae, United StatesContact tracing to control infectious disease: when enough is enoughThe transferrin-iron import system from pathogenic Neisseria species.
P2860
Q24654099-17B6304E-2A13-4CA7-833D-1239F936E157Q24656750-5A52FF1D-899A-42E6-9C24-F62035D0444AQ26862597-6761D61B-FAA4-419D-8361-D3D81F550110Q27009515-87C3A38E-8745-492A-9853-9BC0811184E4Q28484022-0D7D567C-B93B-4B2B-B85C-2ADB9419A45DQ28914762-D1303136-5A44-40A5-BF01-8F9238997544Q30276223-21C13C8C-2E03-459B-80EA-C0EDC8B180E7Q30724177-02DB27DA-EEB6-442F-AA0C-ED61D44E3F39Q30942705-D4924E05-F77E-44A1-8B6B-670A25DEB56CQ33419691-D7352078-0B1C-4F07-BCC6-C97CD334BCD1Q33723577-9E738A11-E5DB-459A-89C0-481A2848844DQ33904699-EBA867D7-ED9D-4D4D-8D50-1324CEDED12FQ33963124-2179F347-7AD1-4386-97BF-A3069B16A35CQ34081308-E52DC356-CEB4-4389-8C04-6086F3C07EEFQ34119205-48BEB328-5581-4F94-8BFE-6075B0BF7738Q34126619-0A93AD33-5C43-4ECD-AB6D-0C7EA06ADD24Q34184518-182DD9FB-EFFA-40C6-8360-635128C331FEQ34479272-96B33B78-BEC9-4E21-9DFD-F997746D0D62Q34495680-1AC66E4E-400F-4359-966F-1B0CDE2C7BD6Q34529041-F6E30EED-DC07-4F0F-9137-3663F64882B5Q34561067-4B1CA5B5-5C73-4B40-A887-375110F83490Q34736808-5E2AA1DC-90E7-43DB-9E4A-A7DEFB5E575CQ35105769-A62046C4-44C7-4538-8B12-BD3D7FCB6B22Q35139554-B59F530F-57DB-4982-877B-8EF19497780AQ35141880-4A6752CF-AA1E-48FF-BF9C-5C44A1E8A2B2Q35147305-C0199386-A7AD-406C-9E35-6A9E2B381D7AQ35167349-A9521845-FB7F-461D-9392-4BD55A72F984Q35214775-FB7763AB-13D6-4D94-98AE-3644545D7852Q35246485-CFAFA548-AD15-4F32-8CA2-6DCCCEB36857Q35385512-5FCF7DB9-A2D3-4AE2-BB54-C5DDD22C733DQ35611039-56E4E259-DD8F-4FDF-A691-C147842ABB1FQ35642295-C6382041-7B5F-4F4D-8BCB-6F44FE7CE33EQ35855037-097F93BF-0891-4494-8D5F-4FCED00F33DFQ35856141-57CB6049-C660-44A0-8988-CD4508D332BEQ35878450-9FE9B964-0C11-450E-B05C-9E1BB8A22B50Q36086135-9846A951-A2DA-496B-A57A-1748AF88D61AQ36137942-CBAFCC53-BF01-412F-907D-0A27DBC5348CQ36147980-494AE3E0-F0B5-4217-90EC-D2F5BB5AD8C6Q36191231-E2439A94-D8BB-40E3-BB63-84E3ECB05657Q36309845-6533BA44-4960-4BFA-96BE-ABE344699887
P2860
Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections
description
2007 nî lūn-bûn
@nan
2007 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Update to CDC's sexually trans ...... tment of gonococcal infections
@ast
Update to CDC's sexually trans ...... tment of gonococcal infections
@en
Update to CDC's sexually trans ...... tment of gonococcal infections
@nl
type
label
Update to CDC's sexually trans ...... tment of gonococcal infections
@ast
Update to CDC's sexually trans ...... tment of gonococcal infections
@en
Update to CDC's sexually trans ...... tment of gonococcal infections
@nl
prefLabel
Update to CDC's sexually trans ...... tment of gonococcal infections
@ast
Update to CDC's sexually trans ...... tment of gonococcal infections
@en
Update to CDC's sexually trans ...... tment of gonococcal infections
@nl
P3181
P1476
Update to CDC's sexually trans ...... tment of gonococcal infections
@en
P3181
P356
10.1016/J.ANNEMERGMED.2007.06.012
P407
P577
2007-04-13T00:00:00Z